304 related articles for article (PubMed ID: 18559924)
1. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
[TBL] [Abstract][Full Text] [Related]
2. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains.
Herfst S; de Graaf M; Schrauwen EJA; Ulbrandt ND; Barnes AS; Senthil K; Osterhaus ADME; Fouchier RAM; van den Hoogen BG
J Gen Virol; 2007 Oct; 88(Pt 10):2702-2709. PubMed ID: 17872522
[TBL] [Abstract][Full Text] [Related]
3. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
4. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
[TBL] [Abstract][Full Text] [Related]
5. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
6. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.
Williams JV; Tollefson SJ; Johnson JE; Crowe JE
J Virol; 2005 Sep; 79(17):10944-51. PubMed ID: 16103146
[TBL] [Abstract][Full Text] [Related]
7. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design.
MacPhail M; Schickli JH; Tang RS; Kaur J; Robinson C; Fouchier RAM; Osterhaus ADME; Spaete RR; Haller AA
J Gen Virol; 2004 Jun; 85(Pt 6):1655-1663. PubMed ID: 15166450
[TBL] [Abstract][Full Text] [Related]
8. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters.
Schickli JH; Kaur J; Macphail M; Guzzetta JM; Spaete RR; Tang RS
Virol J; 2008 Jun; 5():69. PubMed ID: 18519001
[TBL] [Abstract][Full Text] [Related]
9. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
Cseke G; Wright DW; Tollefson SJ; Johnson JE; Crowe JE; Williams JV
J Virol; 2007 Jan; 81(2):698-707. PubMed ID: 17050599
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice.
Lévy C; Aerts L; Hamelin MÈ; Granier C; Szécsi J; Lavillette D; Boivin G; Cosset FL
Vaccine; 2013 Jun; 31(25):2778-85. PubMed ID: 23583815
[TBL] [Abstract][Full Text] [Related]
11. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
12. Human metapneumovirus infection in hospital referred South African children.
IJpma FF; Beekhuis D; Cotton MF; Pieper CH; Kimpen JL; van den Hoogen BG; van Doornum GJ; Osterhaus DM
J Med Virol; 2004 Jul; 73(3):486-93. PubMed ID: 15170647
[TBL] [Abstract][Full Text] [Related]
13. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
14. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections.
Herfst S; Fouchier RA
J Clin Virol; 2008 Jan; 41(1):49-52. PubMed ID: 18054841
[TBL] [Abstract][Full Text] [Related]
15. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
[TBL] [Abstract][Full Text] [Related]
16. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates.
Biacchesi S; Pham QN; Skiadopoulos MH; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2005 Oct; 79(19):12608-13. PubMed ID: 16160190
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a Mixture of Nucleoprotein from Human Metapneumovirus and AbISCO-100 Adjuvant Reduces Viral Infection in Mice Model.
Diaz-Dinamarca DA; Ibañez FJ; Soto DA; Soto JA; Cespedes PF; Muena NA; Garate DS; Kalergis AM; Vasquez AE
Viral Immunol; 2018 May; 31(4):306-314. PubMed ID: 29373084
[TBL] [Abstract][Full Text] [Related]
18. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
[TBL] [Abstract][Full Text] [Related]
19. Experimental infection of adults with recombinant wild-type human metapneumovirus.
Talaat KR; Karron RA; Thumar B; McMahon BA; Schmidt AC; Collins PL; Buchholz UJ
J Infect Dis; 2013 Nov; 208(10):1669-78. PubMed ID: 23908489
[TBL] [Abstract][Full Text] [Related]
20. Live vaccines for human metapneumovirus designed by reverse genetics.
Buchholz UJ; Nagashima K; Murphy BR; Collins PL
Expert Rev Vaccines; 2006 Oct; 5(5):695-706. PubMed ID: 17181442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
